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Objectives: To investigate microRNAs (miRNAs) in urinary exosomes and their association with an
individual's blood pressure response to dietary salt intake.
Design and methods: Human urinary exosomal miRNome was examined by microarray.
Results: Of 1898 probes tested, 194 miRNAs were found in all subjects tested. 45 miRNAs had signiﬁcant
associations with salt sensitivity or inverse salt sensitivity.
Conclusion: The expression of 45 urinary exosomal miRNAs associates with an individual's blood pres-
sure response to sodium.
© 2013 The Authors. The Canadian Society of Clinical Chemists. Published by Elsevier Inc.
Open access under CC BY-NC-ND license.Introduction
Salt sensitivity of blood pressure (BP) is associated with higher in-
cidence of cardiovascular disease independent of hypertension [1];
however, it is difﬁcult to diagnose. The paradoxical decrease in BP fol-
lowing high salt intake, which we term “inverse salt sensitivity” also
may be associated with increased cardiovascular disease and mortal-
ity if sufﬁcient salt intake is not maintained [2]. For these latter indi-
viduals, low salt intake will cause an increase in their BP. The most
effective method in diagnosing either condition is using an extensive
two-week dietary protocol [3]. Finding a simpler method to correctly
diagnose these conditions is critical since salt sensitivity affects
approximately 25% of the population and inverse salt sensitivity
may affect up to 15% [2]. Urinary exosomes provide a unique view
of renal metabolic activity and may provide a valuable source for di-
agnostic biomarkers [2,4].od pressure; SS, salt-sensitive;
.O. Box 801400, Charlottesville,
of Clinical Chemists. Published by EExosomes are 50–90 nm membrane-derived vesicles found in
bodily ﬂuids including blood, saliva, and urine. They encapsulate pro-
teins and mRNA as well as miRNA that may be exchanged as a signal-
ing mechanism between cells [5]. Encapsulated mRNA andmiRNA are
relatively stable because exosomes protect nucleic acids from extra-
cellular degradation [6,7].
miRNAs have been characterized previously in total urine speci-
mens and exosomes from body ﬂuids other than urine, but have yet
to be studied in urinary exosomes. Advances have been made in un-
derstanding the role of miRNAs in cancer pathogenesis, but less is
known about their role in other chronic diseases. Studies have been
reported associating certain miRNAs with hypertension [8] but
miRNAs have not yet been directly linked to sodium metabolism.
Potentially, miRNAs may be exchanged between tubule segments
via exosomes to alter sodiummetabolism in various nephron segments.
To characterize the urinary exosomemiRNome,we usedmicroarrays
to explore the miRNA spectrum present within urinary exosomes from
ten individuals that had completed our salt sensitivity clinical study.
We picked individuals at the two extremes as well as the middle of
the continuous variable of salt sensitivity. One group of individuals had
a dramatic increase in BP when consuming a high sodium diet, i.e.
salt-sensitive. Another group, termed inverse salt-sensitive, had the
opposite response to salt, i.e. their BP dramatically dropped while con-
suming a high sodium diet. These two groups exhibiting extremes of
salt sensitivity of BP were compared to a group of normal individuals
who fell in the middle of this continuum. These normal control individ-
uals had BP that did not change dependent on sodium consumption, i.e.lsevier Inc. Open access under CC BY-NC-ND license.
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sought based on these three phenotypes, deﬁned in more detail below.
Materials and methods
Research participants
Ten Caucasian subjects previously evaluated for their BP response to
controlled sodium intake [3] were asked to participate in this study one
to ﬁve years after their initial classiﬁcation. The study protocol and in-
formed consent documents were approved by the UVA Institutional
Review Board. The three phenotypes identiﬁed were: salt-sensitive (SS,
N = 3) who showed a ≥7 mm Hg increase in mean arterial pressure
(MAP) transitioning from a low to high sodium diet (mean ΔMAP =
+17.5 mm Hg); salt-resistant (SR, N = 4) who had b7 mm Hg change
inMAP following any change in sodium intake (i.e. our normal or control
group); and inverse salt-sensitive (ISS, N = 3) whose MAP decreased
≥7 mm Hg transitioning from a low to high sodium diet (mean
ΔMAP = −12.7 mm Hg) [2,9]. Random urine samples were pooled
from three to four independent collections from each subject. Two inde-
pendent miRNA analyses were performed by microarray.
Exosome puriﬁcation
The ultracentrifugation protocol to isolate exosomes from urine sam-
ples was followed according to Gonzales et al. [10] with the following
modiﬁcations: 1) protease inhibitors were not used because miRNA
was the target and 2) the ﬁrst centrifugation step to remove whole cells
and debris was performed for 30 min rather than 10 min to ensuremax-
imumpurity. Urine specimenswere processed as quickly as possible after
voiding (b4 h) or frozen at−80 °C until processed. Previous studies had
demonstrated thatmiRNA is stable for 24 h in urine at room temperature
[11]. After exosome pellets were resuspended in Phosphate Buffered Sa-
line, total RNAwas isolated using amiRNeasy kit (Qiagen). Sampleswere
stored individually at−80 °C until microarray analysis was performed.
miRNome analysis
Three to four collections per individual were pooled in order to
reach the 5μg miRNA minimum required for enrichment and pre-
ampliﬁcation by a commercial ﬁrm (LC Sciences, Houston, TX). In-
dividual miRNA expression was analyzed using microarray (miRBase
Human: Version 18). To test for analytical variability of the miRNA mi-
croarray chips, each pooled specimen from 5 individuals was split into
two aliquots and each aliquot was analyzed twice. To get a preliminary
understanding of biological variability, we collected and pooled speci-
mens from the same 5 individuals (3 months later) and repeated the
procedure of splitting the pools into two aliquots and analyzing them
in duplicate. The other 5 individuals were examined once in this second
run.
We compared the data from 10 individuals that fell into the three
salt-sensitive phenotypes, 4 individuals that showed a normal re-
sponse to salt (SR), 3 that were SS and 3 that were ISS. The graphs
are displayed as SS individuals compared to SR individuals (Fig. 1A),
and ISS individuals compared to SR individuals (Fig. 1B). Data from
selected datasets were averaged and presented as mean ± standard
error of means. Statistical signiﬁcance was determined using both
Student's t-test and analysis of variance (ANOVA) with Holm–Sidak
correction for multiple comparisons that was applied to compare
the different groups. In our ﬁgure, we report P values from the
Student's t-test; P b 0.05 was considered statistically signiﬁcant.
RT-PCR assays
miRNA that was extracted from all 10 subjects was also analyzed by
quantitative RT-PCR using the miScript PCR System by Qiagen. 80 ng ofthe same RNA samples analyzed by microarray were ﬁrst reverse tran-
scribed (miScript II RT Kit, Qiagen). In order to conﬁrm the microarray
data, 2.5 ng of this DNA was measured by real-time PCR using mature
miRNA-speciﬁc primers (speciﬁc miScript Primer Assay, miScript
SYBR Green PCR kit, Qiagen) in a BioRad CFX connect real-time PCRma-
chine, using standard manufacturer's conditions. The 7 miRNAs that
were picked to conﬁrm the microarray results were: hsa-miR-1268b,
hsa-miR-5002-3p, hsa-miR-4516, hsa-miR-3183, hsa-miR-3940-5p,
hsa-miR-4649-5p, and a control hsa-miR-320a.
Results
Out of the 1898 unique miRNA probes examined by the chips for
miRBase Version 18, a total of 194 were above background in all ten
subjects. These 194 miRNAs replicated within individual aliquots and
between the analytical runs performed 3 months apart. Of the 194
miRNAs detected, 45 were signiﬁcantly different between the SS and
SR individuals or between the ISS and SR subjects. The differences in
urinary exosomal miRNAs between those groups replicated between
pooled sample aliquots and also replicated between the analytical
runs performed 3 months apart.
Four miRNAs shared expression differences between ISS or SS and
their SR control. The only single miRNA that could differentiate the 2
extremes (salt sensitivity or inverse salt sensitivity) vs. the normal SR
group was hsa-miR-4516. This was higher in SS and lower in ISS,
compared to the SR control. One miRNA (hsa-miR-3183) was higher
in SS and ISS vs. SR. 2 miRNA (hsa-miR-3940-5p, hsa-miR-4649-5p)
were lower in SS and ISS vs. SR.
We searched the literature for each of the 45 miRNAs that were
signiﬁcantly different between SS or ISS vs. SR individuals, and
found that only 21 were previously cited as extracellular secreted
miRNAs in serum or other bodily ﬂuids (http://atlas.dmi.unict.it/
mirandola/index.html). The 24 miRNAs that have not been described
as secreted from cells or found in body ﬂuids are highlighted by aster-
isks in the 2 panels of Fig. 1. Currently, these miRNAs can be consid-
ered unique to urinary exosomes and strongly indicate that serum
exosomal miRNAs do not pass into the urine in appreciable quantities.
Six of the mature miRNAs that showed signiﬁcant differences using
microarrayswere veriﬁedusing quantitative RT-PCR. Parallel signiﬁcant
differences were found using real-time RT-PCR that matches themicro-
array analysis (P b 0.05 for each pairwise comparison). A 7th miRNA
was also picked for this assay as a control. This showed no difference
in the PCR between the SR and either SS or ISS, conﬁrming the result
seen in the microassay.
Our data demonstrate that there were signiﬁcant differences in 45
miRNA concentrations in urinary exosomes, presumably derived from
kidney tubule cells. The relative concentration of each miRNA is
shown by pseudocolor representation on the heat maps at the left in
each ﬁgure. There were dramatic differences between the various
miRNA concentrations so the bar graphwas made and scaled to accom-
modate these differences.
Discussion
These results provide the ﬁrst examination of miRNAs present in uri-
nary exosomes. Exosomes aremembrane-derived vesicles that encapsu-
late cytoplasmic contents and thus provide a view of both membrane
and cytoplasmic-based biomolecules, including miRNAs. Previous stud-
ies of circulating miRNAs excreted in urine have demonstrated associa-
tion between presence of disease and changes in the concentration of
urinary-selected miRNAs [11]. However, the interpretation that those
miRNAs are biomarkers for kidney disease is complicated by the fact
that urinary miRNA is composed of a combination of both ﬁltered
miRNA (derived from the blood) as well as kidney-derived miRNA. For
our studies, we used urinary exosomes to exclude miRNA ﬁltered from
Fig. 1. Differential miRNA expression in urine exosomes. miRNA expression patterns of 11 pooled urines were analyzed using miRBase version 18 microarray. In the heat maps on
the left, each column corresponds to the relative expression proﬁle of a pooled urine sample from an individual previously indexed for their blood pressure response to salt. Rep-
licates of specimens per individual are included in the heat map. Student's t-test was used to identify mature miRNAs that were signiﬁcantly different between subjects (P b 0.05).
Panel A shows the 24 miRNAs that were different between the Salt-Resistant (SR) and Salt-Sensitive (SS) individuals. The 11 miRNAs above the horizontal line showed increased
expression in the SS vs. the SR group, and the 13 miRNAs below that line showed decreased expression compared to the SR control. Panel B shows an additional 21 miRNAs that
were different between the Salt-Resistant (SR) and Inverse Salt-Sensitive (ISS) individuals. The miRNAs are positioned similarly to panel A, i.e. those with increased expression
compared to the SR control are above the ones with decreased expression. To the right of the reporter name, asterisks indicate 13 miRNAs in panel A and 11 additional miRNAs
in panel B that have not previously been reported to be circulating. The bar graph on the right (with corresponding P-values) displays the absolute RFU of each speciﬁc miRNA
probe. The top axis displays the values for the low expressers, and a different scale is used on the bottom axis for the high expressing miRNAs, to label the bars to the right of
the dotted line. The microarray hierarchical cluster analysis is depicted along the left edge of the ﬁgure by grouping genes that had the most similar expression patterns.
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glomerulus.
In our study, 24 of the 45 miRNAs that associated with salt sensi-
tivity or inverse salt sensitivity have never been reported as secreted
miRNAs. Some of the miRNAs that we identiﬁed as potential bio-
markers for SS and ISS hypertension have been reported to regulate
known pathways implicated in hypertension, including PPARγ [12],
EGFR [13], TGFβ-1 [14] and PTEN/PI3K signaling [15]. Since changes
in miRNA expression may occur early in disease pathogenesis, we
postulate that urinary exosomal miRNAs may be useful biomarkers
for individuals with aberrant sodium regulatory pathways [6]. In ad-
dition, each segment of the human nephron has distinct sodium reg-
ulatory functions and the transfer of miRNA from one tubule segment
to more distal segments, as exosomes are carried along with the ﬂow
of urine, may mediate trans-tubular segment communication [16].
The identiﬁcation of exosomal membrane markers in fractionated
nephron-speciﬁc exosomes will shed light on the speciﬁc gene regu-
latory function of urinary exosomal miRNA.
The kidney nephron-derived exosomal miRNAs that were identiﬁed
in our study may associate with kidney-speciﬁc metabolic activity, par-
ticularly renal sodium metabolism. Exosomal miRNAs that did not vary
between conditions testedmay serve as renal-speciﬁc controls for future
longitudinal studies. Plasma-speciﬁc exosomal biomarkers may be used
to exclude plasma contamination from occult glomerular diseases.
These studies are the ﬁrst examination of the urinary exosomal
miRNome; however, there are some caveats. The limited quantities of
exosomes secreted into the lumen of the nephron required large pooled
samples from relatively few subjects to be concentrated to yield enough
material for array testing. Thus, these data do not explore the effect of
dietary or temporal biological variation. The design and testing of small-
er customized urinary exosomalmiRNA arrays or RT-PCR panels should
lower analytical costs and allow larger cohorts to be examined.
Conclusion
Investigating renal cellular pathophysiology through the study of
kidney cell-derived extracellular biomarkers has the potential of pro-
viding a deeper understanding of how individuals express unique pat-
terns of salt sensitivity of blood pressure. Ultimately, personalized
therapeutic approaches to controlling salt-related illnesses will result
from these new diagnostic techniques.
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